Childrens Hospital Boston, Dana-Farber Cancer Institute. is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Childrens Hospital Boston, Dana-Farber Cancer Institute. has participated in 9 clinical trials with 4 currently active.
Therapeutic areas: Neuroblastoma.
Sponsors: New Approaches to Neuroblastoma Therapy Consortium.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Childrens Hospital Boston, Dana-Farber Cancer Institute. has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Childrens Hospital Boston, Dana-Farber Cancer Institute. has 9 clinical trials on record, with 4 currently active. Their work covers Neuroblastoma.
Childrens Hospital Boston, Dana-Farber Cancer Institute. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.